SCHEMBL6605319

SCHEMBL6605319

CCC(=O)c1cccc(-c2ccc(F)cc2)c1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
ERCC5 P28715 2/20 0.49
FEN1 P39748 2/20 0.49
MRGPRX4 Q96LA9 1/20 0.47
KAT6A Q92794 1/20 0.47
GRIN2B Q13224 1/20 0.46
MAPK1 P28482 1/20 0.45
KMO O15229 1/20 0.44
LMNA P02545 1/20 0.44
HPGD P15428 1/20 0.44
TSHR P16473 1/20 0.44
ADCY8 P40145 1/20 0.44
ADCY1 Q08828 1/20 0.44
BCL2 P10415 1/20 0.44
TLR8 Q9NR97 1/20 0.44
TLR7 Q9NYK1 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6005391 0.86 L3MBTL1 (0.69) MAPTSMN1; SMN2L3MBTL1ERCC5FEN1
SCHEMBL13957667 0.85 MAPT (0.58) MAPTSMN1; SMN2L3MBTL1ERCC5FEN1
SCHEMBL28837428 0.85 MAPT (0.58) MAPTSMN1; SMN2L3MBTL1ERCC5FEN1
SCHEMBL16178565 0.85 SMN1; SMN2 (0.79) MAPTSMN1; SMN2L3MBTL1ERCC5FEN1
SCHEMBL21309283 0.85 FFAR4 (0.51) ERCC5FEN1MRGPRX4KAT6AGRIN2B
SCHEMBL6570603 0.83 SMN1; SMN2 (0.66) MAPTSMN1; SMN2L3MBTL1ERCC5FEN1
SCHEMBL20646892 0.83 MAPT (0.66) MAPTSMN1; SMN2L3MBTL1GRIN2BHPGD
SCHEMBL7536493 0.83 MAPT (0.56) MAPTSMN1; SMN2L3MBTL1ERCC5FEN1
SCHEMBL8413590 0.83 MAPT (0.56) MAPTSMN1; SMN2L3MBTL1ERCC5FEN1
SCHEMBL28116916 0.83 MAPT (0.56) MAPTSMN1; SMN2L3MBTL1ERCC5FEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1142887-B1 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents PARKE DAVIS & CO (US) 2004-04-07 EP disclosed
EP-0729463-B1 5,6-DIHYDROPYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2002-05-22 EP disclosed
EP-1142887-A1 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents PARKE, DAVIS & COMPANY (US) 2001-10-10 EP disclosed
US-5936128-A BENZENETHIOL COMPOUNDS AS INTERMEDIATES; BACTERICIDES, VIRICIDES; HIV WARNER-LAMBERT COMPANY (US) 1999-08-10 US disclosed
US-5840751-A ADMINISTERING IN THE TREATMENT OF INFECTION OR DISEASE CAUSED BY A RETROVIRUS WARNER-LAMBERT COMPANY (US) 1998-11-24 US disclosed
US-5789440-A 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents WARNER-LAMBERT COMPANY (US) 1998-08-04 US disclosed
EP-0729463-A1 5,6-DIHYDROPYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & COMPANY (US) 1996-09-04 EP disclosed
EP-0729464-A1 5,6-DIHYDROPYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014012-A1 5,6-DIHYDROPYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
WO-1995014011-A2 5,6-DIHYDROPYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed